By Marilynn Larkin November 22, 2021 NEW YORK (Reuters Health) – In adults ages 55 to 64, a single flexible sigmoidoscopy (FS) screening is associated with a substantial reduction in colorectal cancer (CRC) incidence and mortality, with a protective effective lasting up to 18 years, researchers say. “The findings support the hypothesis of a plateau in the...